HomeMy WebLinkAbout18051_Raleigh_Residence_Risk_Assess_VISL_201605051
Kady, Lebeed
From:Mort, Sandra L
Sent:Thursday, May 05, 2016 10:39 AM
To:Eckard, Sharon; Kady, Lebeed
Subject:FW: MW-7 + -8 Raleigh Residence
Attachments:Raleigh.Residence_slm_050516.xlsm
Critical effect analysis for MW‐7 & ‐8 combined maximum concentrations, assuming a residential inhalation exposure
due to vapor intrusion, using a 20C GW temperature –
The hazard index (HI) for potential nervous system impacts = 0.87, and the maximum combined HI for all other critical
effects = 0.31. This analysis indicates that potential indoor air exposure risks do not exceed the cumulative non‐cancer
risk criteria for a residential exposure scenario.
See the attached VISL calculator.
Sandy
________________________________________
Sandy Mort
Environmental Toxicologist / Risk Assessor
Division of Waste Management – Hazardous Waste & Brownfields
NC Department of Environmental Quality
(919) 707-8217 - Direct Line & Fax
sandy.mort@ncdenr.gov
1646 Mail Service Center
Raleigh, NC 27699-1646
Email correspondence to and from this address is subject to the
North Carolina Public Records Law and may be disclosed to third parties.
From: Eckard, Sharon
Sent: Thursday, May 05, 2016 10:18 AM
To: Mort, Sandra L <sandy.mort@ncdenr.gov>; Kady, Lebeed <lebeed.kady@ncdenr.gov>
Subject: RE: MW‐7 + ‐8 Raleigh Residence
Wells MW‐7 & MW‐8 are from the same stratigraphic layer: partially weathered rock so I do think that you could
correctly interpret that both water samples were collected under similar formation conditions.
Sharon Poissant Eckard, PG
Eastern District Supervisor
Division of Waste Management – Brownfields Program
NC Department of Environmental Quality
2
919.707.8379 direct line & fax
sharon.eckard@ncdenr.gov
217 W. Jones Street
1646 Mail Service Center
Raleigh, NC 27699-1646
Email correspondence to and from this address is subject to the
North Carolina Public Records Law and may be disclosed to third parties.
From: Mort, Sandra L
Sent: Thursday, May 05, 2016 10:05 AM
To: Eckard, Sharon <sharon.eckard@ncdenr.gov>; Kady, Lebeed <lebeed.kady@ncdenr.gov>
Subject: MW‐7 + ‐8 Raleigh Residence
Importance: High
Sharon & Labeed‐
When I combine the max concentrations for the 2 wells & use 20C GW temp, we are over the HQ of 1.0. It is also over at
17.5C. So, I need to do a critical effect analysis. I’ll work on it now. ‐‐‐‐ Unless there is some compelling reason why we
should look at these wells as separate entities.
S
________________________________________
Sandy Mort
Environmental Toxicologist / Risk Assessor
Division of Waste Management – Hazardous Waste & Brownfields
NC Department of Environmental Quality
(919) 707-8217 - Direct Line & Fax
sandy.mort@ncdenr.gov
1646 Mail Service Center
Raleigh, NC 27699-1646
Email correspondence to and from this address is subject to the
North Carolina Public Records Law and may be disclosed to third parties.
x x
Gr
o
u
n
d
w
a
t
e
r
C
o
n
c
e
n
t
r
a
t
i
o
n
t
o
I
n
d
o
o
r
A
i
r
C
o
n
c
e
n
t
r
a
t
i
o
n
(
G
W
C
-
I
A
C
)
C
a
l
c
u
l
a
t
o
r
V
e
r
s
i
o
n
3
.
4
5
,
N
o
v
e
m
b
e
r
2
0
1
5
R
S
L
s
x
mo
d
i
f
i
e
d
G
W
t
e
m
p
p
e
r
B
F
s
x
Pa
r
a
m
e
t
e
r
S
y
m
b
o
l
V
a
l
u
e
I
n
s
t
r
u
c
t
i
o
n
s
x
Ex
p
o
s
u
r
e
S
c
e
n
a
r
i
o
S
c
e
n
a
r
i
o
R
e
s
i
d
e
n
t
i
a
l
S
e
l
e
c
t
r
e
s
i
d
e
n
t
i
a
l
o
r
c
o
m
m
e
r
c
i
a
l
s
c
e
n
a
r
i
o
f
r
o
m
p
u
l
l
d
o
w
n
l
i
s
t
x
Ta
r
g
e
t
R
i
s
k
f
o
r
C
a
r
c
i
n
o
g
e
n
s
T
C
R
1
.
0
0
E
-
0
5
x
Ta
r
g
e
t
H
a
z
a
r
d
Q
u
o
t
i
e
n
t
f
o
r
N
o
n
-
C
a
r
c
i
n
o
g
e
n
s
T
H
Q
0
.
2
A ve
r
a
g e
G
r
o
u
n
d
w
a
t
e
r
T
e
m
p era
t
u
r
e
(o C )
T g w2
0
En
t
e
r
a
v
e
r
a
g
e
o
f
t
h
e
s
t
a
b
i
l
i
z
e
d
g
r
o
u
n
d
w
a
t
e
r
t
e
m
p
e
r
a
t
u
r
e
t
o
c
o
r
r
e
c
t
H
e
n
r
y
'
s
L
a
w
C
o
n
s
t
a
n
t
f
o
r
g
r
o
u
n
d
w
a
t
e
r
t
a
r
g
e
t
c
o
n
c
e
n
t
r
a
t
i
o
n
s
x x
Si
t
e
Gr
o
u
n
d
w
a
t
e
r
Co
n
c
e
n
t
r
a
t
i
o
n
Ca
l
c
u
l
a
t
e
d
In
d
o
o
r
A
i
r
Co
n
c
e
n
t
r
a
t
i
o
n
VI
Ca
r
c
i
n
o
g
e
n
i
c
Ris
k
VI
H
a
z
a
r
d
In
h
a
l
a
t
i
o
n
U
n
i
t
Ris
k
Re
f
e
r
e
n
c
e
Co
n
c
e
n
t
r
a
t
i
o
n
x
Cg
w
C
i
a
I
U
R
R
f
C
x
CA
S
C
h
e
m
i
c
a
l
N
a
m
e
(u
g
/
L
)
(u
g
/
m
3 )
(u
g
/
m
3 )-1
(m
g
/
m
3 )
i
71
-
4
3
-
2
B
e
n
z
e
n
e
1
.
3
E
+
0
0
2
.
3
4
E
-
0
1
6
.
5
E
-
0
7
0
.
0
0
7
1
.
5
9
E
+
0
1
7
.
8
0
E
-
0
6
I
3
.
0
0
E
-
0
2
I
immuno, hemato (IRIS)
67
-
6
6
-
3
C
h
l
o
r
o
f
o
r
m
5
.
0
E
-
0
1
6
.
0
5
E
-
0
2
5
.
0
E
-
0
7
0
.
0
0
1
8
.
1
4
E
+
0
0
2
.
3
0
E
-
0
5
I
9
.
8
0
E
-
0
2
A
10
7
-
0
6
-
2
D
i
c
h
l
o
r
o
e
t
h
a
n
e
,
1
,
2
-
1.
5
E
+
0
2
5.6
8
E
+
0
0
5.3
E
-
0
5
0
.
7
7
8
2.2
4
E
+
0
1
2
.
6
0
E
-
0
5
I
7
.
0
0
E
-
0
3
P
Neurological (PPRTV)
10
8
-
2
0
-
3
D
i
i
s
o
p
r
o
p
y
l
E
t
h
e
r
2
.
3
E
+
0
0
2
.
4
1
E
-
0
1
N
o
I
U
R
0
.
0
0
0
1
.
3
9
E
+
0
3
7
.
0
0
E
-
0
1
P
10
0
-
4
1
-
4
E
t
h
y
l
b
e
n
z
e
n
e
7
.
5
E
+
0
0
1
.
8
1
E
+
0
0
1
.
6
E
-
0
6
0
.
0
0
2
3
.
4
9
E
+
0
1
2
.
5
0
E
-
0
6
C
A
1
.
0
0
E
+
0
0
I
developmental (IRIS)
91
-
2
0
-
3
N
a
p
h
t
h
a
l
e
n
e
3
.
0
E
+
0
0
3
.
7
3
E
-
0
2
4
.
5
E
-
0
7
0
.
0
1
2
3
.
4
8
E
+
0
1
3
.
4
0
E
-
0
5
C
A
3
.
0
0
E
-
0
3
I
nervous, respir (IRIS)
10
3
-
6
5
-
1
P
r
o
p
y
l
b
e
n
z
e
n
e
1
.
1
E
+
0
0
3
.
4
2
E
-
0
1
N
o
I
U
R
0
.
0
0
0
4
.
8
6
E
+
0
2
1
.
0
0
E
+
0
0
X
12
7
-
1
8
-
4
T
e
t
r
a
c
h
l
o
r
o
e
t
h
y
l
e
n
e
7
.
0
E
-
0
1
3
.
8
6
E
-
0
1
3
.
6
E
-
0
8
0
.
0
0
9
1
.
1
5
E
+
0
1
2
.
6
0
E
-
0
7
I
4
.
0
0
E
-
0
2
I
nervous, ocular (IRIS)
10
8
-
8
8
-
3
T
o
l
u
e
n
e
8
.
7
E
+
0
0
1
.
8
2
E
+
0
0
N
o
I
U
R
0
.
0
0
0
3
.
8
4
E
+
0
3
5
.
0
0
E
+
0
0
I
79
-
0
1
-
6
T
r
i
c
h
l
o
r
o
e
t
h
y
l
e
n
e
5
.
0
E
-
0
1
1
.
5
8
E
-
0
1
3
.
3
E
-
0
7
0
.
0
7
6
1
.
0
4
E
+
0
0
s
e
e
n
o
t
e
I
2
.
0
0
E
-
0
3
I
T
C
E
cardio, devl, immuno (IRIS)
95
-
6
3
-
6
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
,
1
,
2
,
4
-
8.
9
E
+
0
0
1.6
1
E
+
0
0
N
o
I
U
R
0.
2
2
0
5.8
0
E
+
0
0
7
.
0
0
E
-
0
3
P
clotting/hemato, lung (PPRTV)
13
3
0
-
2
0
-
7
X
y
l
e
n
e
s
3
.
9
E
+
0
1
7
.
9
0
E
+
0
0
N
o
I
U
R
0
.
0
7
6
7
.
6
9
E
+
0
1
1
.
0
0
E
-
0
1
I
nervous, motor coord (IRIS)
Cu
m
u
l
a
t
i
v
e
5.6
E
-
0
5
1.
1
8
1
HI
,
n
e
r
v
o
u
s
0.8
7
R
i
s
k
/
C
u
m
u
l
a
t
i
v
e
HQ
HI
-
n
e
r
v
o
u
s
=
0
.
3
1
No
t
e
s
:
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
(1
)
In
h
a
l
a
t
i
o
n
P
a
t
h
w
a
y
E
x
p
o
s
u
r
e
P
a
r
a
m
e
t
e
r
s
(
R
M
E
)
:
__
_
_
_
_
_
_
_
_
_
_
_
_
Ex
p
o
s
u
r
e
S
c
e
n
a
r
i
o
U
n
i
t
s
S
y
m
b
o
l
V
a
l
u
e
S
y
m
b
o
l
V
a
l
u
e
S
y
m
b
o
l
V
a
l
u
e
Av
e
r
a
g
i
n
g
t
i
m
e
f
o
r
c
a
r
c
i
n
o
g
e
n
s
(
y
r
s
)
A
T
c
_
R
_
G
W
7
0
A Tc
_C _GW
7
0
A Tc
_GW
7
0
Av
e
r
a
g
i
n
g
t
i
m
e
f
o
r
n
o
n
-
c
a
r
c
i
n
o
g
e
n
s
(
y
r
s
)
A
T
n
c
_
R
_
G
W
2
6
A Tn
c
_C _GW
2
5
A tn
c
_GW
2
6
Ex
p
o
s
u
r
e
d
u
r
a
t
i
o
n
(
y
r
s
)
E
D
_
R
_
G
W
26
ED
_
C
_
G
W
25
ED
_
G
W
26
Ex
p
o
s
u
r
e
f
r
e
q
u
e
n
c
y
(
d
a
y
s
/
y
r
)
E
F
_
R
_
G
W
3
5
0
E
F
_
C
_
G
W
2
5
0
E
F
_
G
W
3
5
0
Ex
p
o
s
u
r
e
t
i
m
e
(
h
r
/
d
a
y
)
E
T
_
R
_
G
W
2
4
E
T
_
C
_
G
W
8
E
T
_
G
W
2
4
(2
)
Ge
n
e
r
i
c
A
t
t
e
n
u
a
t
i
o
n
F
a
c
t
o
r
s
:
So
u
r
c
e
M
e
d
i
u
m
o
f
V
a
p
o
r
s
Sy
m
b
o
l
V
a
l
u
e
S
y
m
b
o
l
V
a
l
u
e
S
y
m
b
o
l
V
a
l
u
e
Gr
o
u
n
d
w
a
t
e
r
(
-
)
A
F
g
w
_
R
_
G
W
0
.
0
0
1
A
F
g
w
_
C
_
G
W
0
.
0
0
1
A
F
g
w
_
G
W
0
.
0
0
1
Su
b
-
S
l
a
b
a
n
d
E
x
t
e
r
i
o
r
S
o
i
l
G
a
s
(
-
)
A
F
s
s
_
R
_
G
W
0
.
0
3
A
F
s
s
_
C
_
G
W
0
.
0
1
A
F
s
s
_
G
W
0
.
0
3
(3
)
Fo
r
m
u
l
a
s
Cia
,
t
a
r
g
e
t
=
M
I
N
(
C
i
a
,
c
;
C
i
a
,
n
c
)
Cia
,
c
(
u
g
/
m
3
)
=
T
C
R
x
A
T
c
x
(
3
6
5
d
a
y
s
/
y
r
)
x
(
2
4
h
r
s
/
d
a
y
)
/
(
E
D
x
E
F
x
E
T
x
I
U
R
)
Cia
,
n
c
(
u
g
/
m
3
)
=
T
H
Q
x
A
T
n
c
x
(
3
6
5
d
a
y
s
/
y
r
)
x
(
2
4
h
r
s
/
d
a
y
)
x
R
f
C
x
(
1
0
0
0
u
g
/
m
g
)
/
(
E
D
x
E
F
x
E
T
)
(4
)
Sp
e
c
i
a
l
C
a
s
e
C
h
e
m
i
c
a
l
s
Tr
i
c
h
l
o
r
o
e
t
h
y
l
e
n
e
Sy
m
b
o
l
V
a
l
u
e
S
y
m
b
o
l
V
a
l
u
e
S
y
m
b
o
l
V
a
l
u
e
mIU
R
T
C
E
_
R
_
G
W
1
.
0
0
E
-
0
6
m IU
R
T
C
E
_C _GW
0
.
0
0
E
+
0
0
m
I
U
R
T
C
E
_
G
W
1
.
0
0
E
-
0
6
IU
R
T
C
E
_
R
_
G
W
3
.
1
0
E
-
0
6
I
U
R
T
C
E
_
C
_
G
W
4
.
1
0
E
-
0
6
I
U
R
T
C
E
_
G
W
3
.
1
0
E
-
0
6
Mu
t
a
g
e
n
i
c
C
h
e
m
i
c
a
l
s
Th
e
e
x
p
o
s
u
r
e
d
u
r
a
t
i
o
n
s
a
n
d
a
g
e
-
d
e
p
e
n
d
e
n
t
a
d
j
u
s
t
m
e
n
t
f
a
c
t
o
r
s
f
o
r
m
u
t
a
g
e
n
i
c
-
m
o
d
e
-
o
f
-
a
c
t
i
o
n
a
r
e
l
i
s
t
e
d
i
n
t
h
e
t
a
b
l
e
b
e
l
o
w
:
0 -
2
y
e
a
r
s
2
2 -
6
y
e
a
r
s
4
6
-
1
6
y
e
a
r
s
1
0
16
-
2
6
y
e
a
r
s
1
0
Mu
t
a
g
e
n
i
c
-
m
o
d
e
-
o
f
-
a
c
t
i
o
n
(
M
M
O
A
)
a
d
j
u
s
t
m
e
n
t
f
a
c
t
o
r
Th
i
s
f
a
c
t
o
r
i
s
u
s
e
d
i
n
t
h
e
e
q
u
a
t
i
o
n
s
f
o
r
m
u
t
a
g
e
n
i
c
c
h
e
m
i
c
a
l
s
.
Vin
y
l
C
h
l
o
r
i
d
e
S
e
e
t
h
e
N
a
v
i
g
a
t
i
o
n
G
u
i
d
e
e
q
u
a
t
i
o
n
f
o
r
C
i
a
,
c
f
o
r
v
i
n
y
l
c
h
l
o
r
i
d
e
.
No
t
a
t
i
o
n
:
I
=
I
R
I
S
:
E
P
A
I
n
t
e
g
r
a
t
e
d
R
i
s
k
I
n
f
o
r
m
a
t
i
o
n
S
y
s
t
e
m
(
I
R
I
S
)
.
A
v
a
i
l
a
b
l
e
o
n
l
i
n
e
a
t
:
h
t
t
p
:
/
/
w
w
w
.
e
p
a
.
g
o
v
/
i
r
i
s
/
s
u
b
s
t
/
i
n
d
e
x
.
h
t
m
l
P =
P
P
R
T
V
.
E
P
A
P
r
o
v
i
s
i
o
n
a
l
P
e
e
r
R
e
v
i
e
w
e
d
T
o
x
i
c
i
t
y
V
a
l
u
e
s
(
P
P
R
T
V
s
)
.
A
v
a
i
l
a
b
l
e
o
n
l
i
n
e
a
t
:
ht
t
p
:
/
/
h
h
p
p
r
t
v
.
o
r
n
l
.
g
o
v
/
p
p
r
t
v
.
s
h
t
m
l
A =
A
g
e
n
c
y
f
o
r
T
o
x
i
c
S
u
b
s
t
a
n
c
e
s
a
n
d
D
i
s
e
a
s
e
R
e
g
i
s
t
r
y
(
A
T
S
D
R
)
M
i
n
i
m
u
m
R
i
s
k
L
e
v
e
l
s
(
M
R
L
s
)
.
A
v
a
i
l
a
b
l
e
o
n
l
i
n
e
a
t
:
ht
t
p
:
/
/
w
w
w
.
a
t
s
d
r
.
c
d
c
.
g
o
v
/
m
r
l
s
/
i
n
d
e
x
.
h
t
m
l
Target Organ / Critical Effect Analysis, Non-Cancer (Inhalation Exposure)
Ma
x
c
o
m
b
i
n
e
d
c
o
n
c
e
n
t
r
a
t
i
o
n
s
p
a
s
s
e
s
on
c
r
i
t
i
c
a
l
e
f
f
e
c
t
a
n
a
l
y
s
i
s
;
S
L
M
o
r
t
,
5/5/16
If
c
u
m
u
l
a
t
i
v
e
r
i
s
k
>
1
.
0
E
-
0
4
o
r
c
u
m
u
l
a
t
i
v
e
H
Q
>
1
.
0
Un
a
c
c
e
p
t
a
b
l
e
RF
C
So
u
r
c
e
*
IU
R
So
u
r
c
e
*
Mu
t
a
g
e
n
i
c
In
d
i
c
a
t
o
r
CR
H
Q
Gr
o
u
n
d
w
a
t
e
r
Sc
r
e
e
n
i
n
g
Le
v
e
l
(
u
g
/
l
)
IH
S
B
-
B
r
o
w
n
f
i
e
l
d
s
V
a
p
o
r
I
n
t
r
u
s
i
o
n
C
a
l
c
u
l
a
t
o
r
-
B
a
s
e
d
o
n
O
S
W
E
R
V
A
P
O
R
I
N
T
R
U
S
I
O
N
A
S
S
E
S
S
M
E
N
T
Ra
l
e
i
g
h
R
e
s
i
d
e
n
c
e
,
M
W
-
7
&
-
8
SL
M
o
r
t
5
/
5
/
1
6
;
d
a
t
a
e
n
t
r
y
&
c
r
i
t
i
c
a
l
e
f
f
f
e
c
t
a
n
a
l
y
s
i
s
En
t
e
r
t
a
r
g
e
t
r
i
s
k
f
o
r
c
a
r
c
i
n
o
g
e
n
s
(
f
o
r
c
o
m
p
a
r
i
s
o
n
t
o
t
h
e
c
a
l
c
u
l
a
t
e
d
V
I
c
a
r
c
i
n
o
g
e
n
i
c
r
i
s
k
i
n
c
o
l
u
m
n
F
)
En
t
e
r
t
a
r
g
e
t
h
a
z
a
r
d
q
u
o
t
i
e
n
t
f
o
r
n
o
n
-
c
a
r
c
i
n
o
g
e
n
s
(
f
o
r
c
o
m
p
a
r
i
s
o
n
t
o
t
h
e
c
a
l
c
u
l
a
t
e
d
V
I
h
a
z
a
r
d
i
n
c
o
l
u
m
n
G
)
3 1 72
Se
l
e
c
t
e
d
(
b
a
s
e
d
o
n
s
c
e
n
a
r
i
o
)
Se
l
e
c
t
e
d
(
b
a
s
e
d
o
n
s
c
e
n
a
r
i
o
)
Se
l
e
c
t
e
d
(
b
a
s
e
d
o
n
s
c
e
n
a
r
i
o
)
Re
s
i
d
e
n
t
i
a
l
C
o
m
m
e
r
c
i
a
l
Re
s
i
d
e
n
t
i
a
l
C
o
m
m
e
r
c
i
a
l
Re
s
i
d
e
n
t
i
a
l
C
o
m
m
e
r
c
i
a
l
No
t
e
:
T
h
i
s
s
e
c
t
i
o
n
a
p
p
l
i
e
s
t
o
t
r
i
c
h
l
o
r
o
e
t
h
y
l
e
n
e
a
n
d
o
t
h
e
r
mu
t
a
g
e
n
i
c
c
h
e
m
i
c
a
l
s
,
b
u
t
n
o
t
t
o
v
i
n
y
l
c
h
l
o
r
i
d
e
.
Ag
e
C
o
h
o
r
t
Ex
p
o
s
u
r
e
Du
r
a
t
i
o
n
Ag
e
-
d
e
p
e
n
d
e
n
t
a
d
j
u
s
t
m
e
n
t
fa
c
t
o
r
10 3
VI
S
L
C
a
l
c
u
l
a
t
o
r
V
e
r
s
i
o
n
3
.
4
.
5
,
N
o
v
e
m
b
e
r
2
0
1
5
R
S
L
s
Page 1 of 2
x x
Gr
o
u
n
d
w
a
t
e
r
C
o
n
c
e
n
t
r
a
t
i
o
n
t
o
I
n
d
o
o
r
A
i
r
C
o
n
c
e
n
t
r
a
t
i
o
n
(
G
W
C
-
I
A
C
)
C
a
l
c
u
l
a
t
o
r
V
e
r
s
i
o
n
3
.
4
5
,
N
o
v
e
m
b
e
r
2
0
1
5
R
S
L
s
x
mo
d
i
f
i
e
d
G
W
t
e
m
p
p
e
r
B
F
s
x
Pa
r
a
m
e
t
e
r
S
y
m
b
o
l
V
a
l
u
e
I
n
s
t
r
u
c
t
i
o
n
s
x
Ex
p
o
s
u
r
e
S
c
e
n
a
r
i
o
S
c
e
n
a
r
i
o
R
e
s
i
d
e
n
t
i
a
l
S
e
l
e
c
t
r
e
s
i
d
e
n
t
i
a
l
o
r
c
o
m
m
e
r
c
i
a
l
s
c
e
n
a
r
i
o
f
r
o
m
p
u
l
l
d
o
w
n
l
i
s
t
x
Ta
r
g
e
t
R
i
s
k
f
o
r
C
a
r
c
i
n
o
g
e
n
s
T
C
R
1
.
0
0
E
-
0
5
x
Ta
r
g
e
t
H
a
z
a
r
d
Q
u
o
t
i
e
n
t
f
o
r
N
o
n
-
C
a
r
c
i
n
o
g
e
n
s
T
H
Q
0
.
2
A ve
r
a
g e
G
r
o
u
n
d
w
a
t
e
r
T
e
m
p era
t
u
r
e
(o C )
T g w2
0
En
t
e
r
a
v
e
r
a
g
e
o
f
t
h
e
s
t
a
b
i
l
i
z
e
d
g
r
o
u
n
d
w
a
t
e
r
t
e
m
p
e
r
a
t
u
r
e
t
o
c
o
r
r
e
c
t
H
e
n
r
y
'
s
L
a
w
C
o
n
s
t
a
n
t
f
o
r
g
r
o
u
n
d
w
a
t
e
r
t
a
r
g
e
t
c
o
n
c
e
n
t
r
a
t
i
o
n
s
x x
Si
t
e
Gr
o
u
n
d
w
a
t
e
r
Co
n
c
e
n
t
r
a
t
i
o
n
Ca
l
c
u
l
a
t
e
d
In
d
o
o
r
A
i
r
Co
n
c
e
n
t
r
a
t
i
o
n
VI
Ca
r
c
i
n
o
g
e
n
i
c
Ris
k
VI
H
a
z
a
r
d
In
h
a
l
a
t
i
o
n
U
n
i
t
Ris
k
Re
f
e
r
e
n
c
e
Co
n
c
e
n
t
r
a
t
i
o
n
x
Cg
w
C
i
a
I
U
R
R
f
C
x
CA
S
C
h
e
m
i
c
a
l
N
a
m
e
(u
g
/
L
)
(u
g
/
m
3 )
(u
g
/
m
3 )-1
(m
g
/
m
3 )
i
Target Organ / Critical Effect Analysis, Non-Cancer (Inhalation Exposure)
RF
C
So
u
r
c
e
*
IU
R
So
u
r
c
e
*
Mu
t
a
g
e
n
i
c
In
d
i
c
a
t
o
r
CR
H
Q
Gr
o
u
n
d
w
a
t
e
r
Sc
r
e
e
n
i
n
g
Le
v
e
l
(
u
g
/
l
)
IH
S
B
-
B
r
o
w
n
f
i
e
l
d
s
V
a
p
o
r
I
n
t
r
u
s
i
o
n
C
a
l
c
u
l
a
t
o
r
-
B
a
s
e
d
o
n
O
S
W
E
R
V
A
P
O
R
I
N
T
R
U
S
I
O
N
A
S
S
E
S
S
M
E
N
T
Ra
l
e
i
g
h
R
e
s
i
d
e
n
c
e
,
M
W
-
7
&
-
8
SL
M
o
r
t
5
/
5
/
1
6
;
d
a
t
a
e
n
t
r
y
&
c
r
i
t
i
c
a
l
e
f
f
f
e
c
t
a
n
a
l
y
s
i
s
En
t
e
r
t
a
r
g
e
t
r
i
s
k
f
o
r
c
a
r
c
i
n
o
g
e
n
s
(
f
o
r
c
o
m
p
a
r
i
s
o
n
t
o
t
h
e
c
a
l
c
u
l
a
t
e
d
V
I
c
a
r
c
i
n
o
g
e
n
i
c
r
i
s
k
i
n
c
o
l
u
m
n
F
)
En
t
e
r
t
a
r
g
e
t
h
a
z
a
r
d
q
u
o
t
i
e
n
t
f
o
r
n
o
n
-
c
a
r
c
i
n
o
g
e
n
s
(
f
o
r
c
o
m
p
a
r
i
s
o
n
t
o
t
h
e
c
a
l
c
u
l
a
t
e
d
V
I
h
a
z
a
r
d
i
n
c
o
l
u
m
n
G
)
CA
=
C
a
l
i
f
o
r
n
i
a
E
n
v
i
r
o
n
m
e
n
t
a
l
P
r
o
t
e
c
t
i
o
n
A
g
e
n
c
y
/
O
f
f
i
c
e
o
f
E
n
v
i
r
o
n
m
e
n
t
a
l
H
e
a
l
t
h
H
a
z
a
r
d
A
s
s
e
s
s
m
e
n
t
a
s
s
e
s
s
m
e
n
t
s
.
A
v
a
i
l
a
b
l
e
o
n
l
i
n
e
a
t
:
ht
t
p
:
/
/
w
w
w
.
o
e
h
h
a
.
c
a
.
g
o
v
/
r
i
s
k
/
C
h
e
m
i
c
a
l
D
B
/
i
n
d
e
x
.
a
s
p
H =
H
E
A
S
T
.
E
P
A
S
u
p
e
r
f
u
n
d
H
e
a
l
t
h
E
f
f
e
c
t
s
A
s
s
e
s
s
m
e
n
t
S
u
m
m
a
r
y
T
a
b
l
e
s
(
H
E
A
S
T
)
d
a
t
a
b
a
s
e
.
A
v
a
i
l
a
b
l
e
o
n
l
i
n
e
a
t
:
ht
t
p
:
/
/
e
p
a
-
h
e
a
s
t
.
o
r
n
l
.
g
o
v
/
h
e
a
s
t
.
s
h
t
m
l
S =
S
e
e
R
S
L
U
s
e
r
G
u
i
d
e
,
S
e
c
t
i
o
n
5
X =
P
P
R
T
V
A
p
p
e
n
d
i
x
Mu
t
=
C
h
e
m
i
c
a
l
a
c
t
s
a
c
c
o
r
d
i
n
g t
o
t
h
e
m
u
t
a
g en
i
c
-
m
o
d
e
-
o
f
-
a
c
t
i
o
n
,
s
p ec
i
a
l
e
x
p os
u
r
e
p ar
a
m
e
t
e
r
s
a
pp
l y (se
e
f
o
o
t
n
o
t
e
(4 ) a
b
o
v
e
).
VC
=
S
p
e
c
i
a
l
e
x
p
o
s
u
r
e
e
q
u
a
t
i
o
n
f
o
r
v
i
n
y
l
c
h
l
o
r
i
d
e
a
p
p
l
i
e
s
(
s
e
e
N
a
v
i
g
a
t
i
o
n
G
u
i
d
e
f
o
r
e
q
u
a
t
i
o
n
)
.
TC
E
=
S
p
e
c
i
a
l
m
u
t
a
g
e
n
i
c
a
n
d
n
o
n
-
m
u
t
a
g
e
n
i
c
I
U
R
s
f
o
r
t
r
i
c
h
l
o
r
o
e
t
h
y
l
e
n
e
a
p
p
l
y
(
s
e
e
f
o
o
t
n
o
t
e
(
4
)
a
b
o
v
e
)
.
Ye
l
l
o
w
h
i
g
h
l
i
g
h
t
i
n
g
i
n
d
i
c
a
t
e
s
s
i
t
e
-
s
p
e
c
i
f
i
c
p
a
r
a
m
e
t
e
r
s
t
h
a
t
m
a
y
b
e
e
d
i
t
e
d
b
y
t
h
e
u
s
e
r
.
Blu
e
h
i
g hli
g hti
n
g in
d
i
c
a
t
e
s
e
x
p os
u
r
e
f
a
c
t
o
r
s
t
h
a
t
a
r
e
b
a
s
e
d
o
n
R
i
s
k
A
s
s
e
s
s
m
e
n
t
G
u
i
d
a
n
c
e
f
o
r
S
u
p er
f
u
n
d
(RA
G
S
) o
r
E
P
A
v
a
p or
i
n
t
r
u
s
i
o
n
g uid
a
n
c
e
,
w
h
i
c
h
g en
e
r
a
l
l
y s
h
o
u
l
d
n
o
t
b
e
c
h
a
n
g ed
.
Pin
k
h
i
g
h
l
i
g
h
t
i
n
g
i
n
d
i
c
a
t
e
s
V
I
c
a
r
c
i
n
o
g
e
n
i
c
r
i
s
k
g
r
e
a
t
e
r
t
h
a
n
t
h
e
t
a
r
g
e
t
r
i
s
k
f
o
r
c
a
r
c
i
n
o
g
e
n
s
(
T
C
R
)
o
r
V
I
H
a
z
a
r
d
g
r
e
a
t
e
r
t
h
a
n
o
r
e
q
u
a
l
t
o
t
h
e
t
a
r
g
e
t
h
a
z
a
r
d
q
u
o
t
i
e
n
t
f
o
r
n
o
n
-
c
a
r
c
i
n
o
g
e
n
s
(
T
H
Q
)
.
VI
S
L
C
a
l
c
u
l
a
t
o
r
V
e
r
s
i
o
n
3
.
4
.
5
,
N
o
v
e
m
b
e
r
2
0
1
5
R
S
L
s
Page 2 of 2